Catheter-related fungemia caused by Candida dubliniensis

Journal of Microbiology, Immunology and Infection

Volumn 46, Issue 4, 2013, Pages 306-308

  Lai, Chih Cheng ^a   Tsai, Hsih Yeh ^b,c   Chang, Tsung Chain ^d   Hsueh, Po Ren ^c  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Candida albicans; Candida dubliniensis; Catheter related candidemia

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; CEFEPIME; CEFTAZIDIME; ERTAPENEM; FLUCONAZOLE; FLUCYTOSINE; ITRACONAZOLE; MICAFUNGIN; PIPERACILLIN PLUS TAZOBACTAM; VORICONAZOLE;

ADULT; AGED; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANCER PATIENT; CANDIDA DUBLINIENSIS; CANDIDEMIA; CASE REPORT; CATHETER INFECTION; CATHETER REMOVAL; FEMALE; FUNGUS ISOLATION; HUMAN; IN VITRO STUDY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; SEQUENCE ANALYSIS; TAIWAN; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 84882262687     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2012.10.001     Document Type: Article

References (14)

1. Lai C.C., Tan C.K., Huang Y.T., Shao P.L., Hsueh P.R. Current challenges in the management of invasive fungal infections. J Infect Chemother 2008, 14:77-85.
2. Lai C.C., Gau S.J., Tan C.K. Distribution of Candida species causing bloodstream infections. J Microbiol Immunol Infect 2012, 45:161-162.
3. Chi H.W., Yang Y.S., Shang S.T., Chen K.H., Yeh K.M., Chang F.Y., et al. Candida albicans versus non-albicans bloodstream infections: the comparison of risk factors and outcome. J Microbiol Immunol Infect 2011, 44:369-375.
4. Sullivan D.J., Westerneng T.J., Haynes K.A., Bennett D.E., Coleman D.C. Candida dubliniensis sp. nov.: phenotypic and molecular characterization of a novel species associated with oral candidiasis in HIV-infected individuals. Microbiology 1995, 141:1507-1521.
5. Wu C.J., Lee H.C., Yang Y.L., Chang C.M., Chen H.T., Lin C.C., et al. Oropharyngeal yeast colonization in HIV-infected outpatients in southern Taiwan: CD4 count, efavirenz therapy and intravenous drug use matter. Clin Microbiol Infect 2012, 18:485-490.
6. Hsiue H.C., Huang Y.T., Kuo Y.L., Liao C.H., Chang T.C., Hsueh P.R. Rapid identification of fungal pathogens in positive blood cultures using oligonucleotide array hybridization. Clin Microbiol Infect 2010, 16:493-500.
7. Reference method for broth microdilution antifungal susceptibility testing of yeasts 2008, Clinical and Laboratory Standards Institute, Third informational supplement M27-S3, Clinical and Laboratory Standards Institute, Wayne, PA.
8. Brandt M.E., Harrison L.H., Pass M., Sofair A.N., Huie S., Li R.K., et al. Candida dubliniensis fungemia: the first four cases in North America. Emerg Infect Dis 2000, 6:46-49.
9. Marriott D., Laxton M., Harkness J. Candida dubliniensis candidemia in Australia. Emerg Infect Dis 2001, 7:479.
10. Jabra-Rizk M.A., Johnson J.K., Forrest G., Mankes K., Meiller T.F., Venezia R.A. Prevalence of Candidemia dubliniensis fungemia at a large teaching hospital. Clin Infect Dis 2005, 41:1064-1067.
11. Bosco-Borgeat M.E., Taverna C.G., Cordoba S., Isla M.G., Murisengo O.A., Szusz W., et al. Prevalence of Candida dubliniensis fungemia in Argentina: identification by a novel multiplex PCR and comparison of different pheynotypic methods. Mycophathologia 2011, 172:407-414.
12. Chen S., Slavin M., Nguyen Q., Marriott D., Playford E.G., Ellis D., et al. Australian Candidemia Study. Active surveillance for candidemia, Australia. Emerg Infect Dis 2006, 12:1508-1509.
13. Chen S.C., Marriott D., Playford E.G., Nguyen Q., Ellis D., Meyer W., et al. Australian Candidaemia Study. Candidemia with uncommon Candida species: predisposing factors, outcome, antifungal susceptibility, and implications for management. Clin Microbiol Infect 2009, 15:662-669.
14. Khan Z., Ahmad S., Joseph L., Chandy R. Candida dubliniensis: an appraisal of its clinical significance as a bloodstream pathogen. PLoS One 2012, 7. e32952.